SMTL ID : 3g5e.1

Human aldose reductase complexed with IDD 740 inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.80 Å

Oligo State

monomer

Ligands

1 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)

NDP.1: 33 residues within 4Å: Chain A: G.22, T.23, W.24, K.25, D.47, Y.52, K.81, H.114, W.115, S.163, N.164, Q.187, Y.213, S.214, P.215, L.216, G.217, S.218, P.219, D.220, L.232, A.249, I.264, P.265, K.266, S.267, V.268, T.269, R.272, E.275, N.276, C.302 Ligands: Q74.2 32 PLIP interactions: 32 interactions with chain A Hydrophobic interactions: A:W.24 Hydrogen bonds: A:T.23, A:W.24, A:D.47, A:S.163, A:N.164, A:Q.187, A:S.214, A:L.216, A:G.217, A:S.218, A:S.218, A:D.220, A:D.220, A:K.266, A:S.267, A:V.268, A:T.269, A:T.269, A:E.275, A:N.276 Water bridges: A:D.220, A:A.249, A:K.266, A:R.272, A:R.272, A:R.272 Salt bridges: A:K.25, A:K.266, A:R.272 pi-Stacking: A:Y.213 pi-Cation interactions: A:R.272

1 x Q74: 2-(3-((4,5,7-trifluorobenzo[d]thiazol-2-yl)methyl)-1H-pyrrolo[2,3-b]pyridin-1-yl)acetic acid(Non-covalent)

Q74.2: 16 residues within 4Å: Chain A: W.24, Y.52, W.83, C.84, H.114, W.115, T.117, F.119, F.126, W.223, A.303, L.304, C.307, Y.313, P.314 Ligands: NDP.1 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:W.115, A:F.119, A:F.126, A:W.223, A:W.223 Hydrogen bonds: A:Y.52 Salt bridges: A:H.114 pi-Stacking: A:W.115, A:W.115 Halogen bonds: A:C.84

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Van Zandt, M.C. et al., Discovery of [3-(4,5,7-trifluoro-benzothiazol-2-ylmethyl)-pyrrolo[2,3-b]pyridin-1-yl]acetic acids as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complications. Bioorg.Med.Chem.Lett. (2009)

Release Date

2009-03-24

Peptides

Aldose reductase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Aldose reductase

Related Entries With Identical Sequence